MSD, known as Merck in the United States and Canada, and the Singapore Economic Development Board today jointly announced the signing of a new agreement under which MSD will expand its presence in Singapore through new manufacturing, marketing, and research investments.  The new agreement provides MSD with a long-term vision for its operations across all facets of its business in Singapore.

Under the agreement, MSD will invest over USD $250 million over the next ten years in site improvements at its manufacturing facilities in Tuas, in addition to expanding its biotech operations, adding technology capability to support new product launches and committing to new expenditures of S$700 million on local research activities.

MSD and Economic Development Board Sign Long-Term Agreement for Significant New Investments in Singapore [35.2 KB]